Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CGC logo

Canopy Growth Corp (CGC)CGC

Upturn stock ratingUpturn stock rating
Canopy Growth Corp
$3.94
Delayed price
Profit since last BUY-29.52%
SELL
upturn advisory
SELL since 1 day
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

11/12/2024: CGC (1-star) is a SELL. SELL since 1 days. Profits (-29.52%). Updated daily EoD!

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: SELL
Historic Profit: -74.82%
Upturn Advisory Performance Upturn Advisory Performance1
Avg. Invested days: 17
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 11/12/2024
Type: Stock
Today’s Advisory: SELL
Historic Profit: -74.82%
Avg. Invested days: 17
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 11/12/2024
Upturn Advisory Performance Upturn Advisory Performance1

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 533.55M USD
Price to earnings Ratio -
1Y Target Price 4.11
Dividends yield (FY) -
Basic EPS (TTM) -5.1
Volume (30-day avg) 6639968
Beta 1.78
52 Weeks Range 2.75 - 14.92
Updated Date 11/11/2024
Company Size Small-Cap Stock
Market Capitalization 533.55M USD
Price to earnings Ratio -
1Y Target Price 4.11
Dividends yield (FY) -
Basic EPS (TTM) -5.1
Volume (30-day avg) 6639968
Beta 1.78
52 Weeks Range 2.75 - 14.92
Updated Date 11/11/2024

Earnings Date

Report Date 2024-11-08
When BeforeMarket
Estimate -0.27
Actual -1.06
Report Date 2024-11-08
When BeforeMarket
Estimate -0.27
Actual -1.06

Profitability

Profit Margin -201.27%
Operating Margin (TTM) -39.87%

Management Effectiveness

Return on Assets (TTM) -4.84%
Return on Equity (TTM) -93.03%

Revenue by Products

Revenue by Products - Current and Previous Year

Revenue by Geography

Revenue by Geography - Current and Previous Year

Valuation

Trailing PE -
Forward PE -
Enterprise Value 702076876
Price to Sales(TTM) 1.9
Enterprise Value to Revenue 3.48
Enterprise Value to EBITDA -1.06
Shares Outstanding 105360000
Shares Floating 105226417
Percent Insiders 0.2
Percent Institutions 9.55
Trailing PE -
Forward PE -
Enterprise Value 702076876
Price to Sales(TTM) 1.9
Enterprise Value to Revenue 3.48
Enterprise Value to EBITDA -1.06
Shares Outstanding 105360000
Shares Floating 105226417
Percent Insiders 0.2
Percent Institutions 9.55

Analyst Ratings

Rating 2.58
Target Price 1.34
Buy 1
Strong Buy -
Hold 7
Sell 2
Strong Sell 2
Rating 2.58
Target Price 1.34
Buy 1
Strong Buy -
Hold 7
Sell 2
Strong Sell 2

AI Summarization

Company Profile:

Canopy Growth Corp is a Canadian-based cannabis company founded in 2013, with its headquarters in Smiths Falls, Ontario. The company was one of the first federally regulated, licensed producers of medical cannabis in Canada and has since expanded its operations globally. Canopy Growth Corp operates in various segments of the cannabis market, including production, distribution, and research and development.

The core business areas of Canopy Growth Corp include cultivating, processing, and selling a diverse range of cannabis products for both medical and recreational use. The company also engages in strategic partnerships and acquisitions to expand its market presence and product offerings. Canopy Growth Corp is known for its innovative cannabis products, including oils, capsules, edibles, and vaporizers, catering to a wide range of consumer preferences.

The leadership team of Canopy Growth Corp is led by CEO David Klein, who brings years of experience in the cannabis industry and has been instrumental in the company's growth and expansion. The corporate structure of Canopy Growth Corp includes various departments such as operations, marketing, research and development, and finance, each playing a crucial role in driving the company's overall strategy and performance.

Top Products and Market Share:

Canopy Growth Corp's top products include its range of cannabis oils, edibles, and vaporizer products, which are popular among both medical and recreational cannabis users. The company has a significant market share in Canada, where it is one of the largest cannabis producers and distributors. In the US, Canopy Growth Corp has been focusing on expanding its presence through strategic partnerships and acquisitions, aiming to capture a larger share of the growing cannabis market.

In comparison to its competitors, Canopy Growth Corp has differentiated itself through its focus on innovation and product quality, which has helped the company gain a loyal customer base and maintain a competitive edge in the industry.

Total Addressable Market:

The total addressable market for Canopy Growth Corp encompasses the global cannabis industry, which is projected to reach billions of dollars in the coming years. With increasing legalization and acceptance of cannabis for medical and recreational use, the market potential for Canopy Growth Corp is vast, offering numerous growth opportunities for the company to explore.

Financial Performance:

In recent years, Canopy Growth Corp has shown strong financial performance, with consistent revenue growth and improving profit margins. The company's revenue has been driven by increased demand for its cannabis products, both in Canada and internationally. However, Canopy Growth Corp has also faced challenges such as regulatory changes, supply chain issues, and increased competition, which have impacted its profitability.

Year-over-year financial performance comparison shows that Canopy Growth Corp has been able to maintain steady growth, despite market volatility and regulatory uncertainties. The company's cash flow statements and balance sheet health indicate a solid financial position, with healthy liquidity and manageable debt levels.

Dividends and Shareholder Returns:

Canopy Growth Corp has not historically paid dividends to shareholders, as the company has been focused on reinvesting profits back into its growth and expansion initiatives. Shareholder returns for Canopy Growth Corp have been driven by stock price appreciation and potential capital gains, rather than dividend payouts.

Growth Trajectory:

Over the past decade, Canopy Growth Corp has experienced rapid growth, expanding its operations globally and diversifying its product portfolio. The company's future growth prospects are promising, as it continues to innovate and capitalize on new market opportunities. Recent product launches and strategic initiatives have positioned Canopy Growth Corp for sustained growth in the cannabis industry.

Market Dynamics:

The cannabis industry is dynamic and evolving, with changing regulations, consumer preferences, and technological advancements shaping the market landscape. Canopy Growth Corp operates in a competitive market environment, where it faces challenges such as pricing pressures, regulatory hurdles, and shifting consumer trends. However, the company's adaptability and focus on product quality and innovation have enabled it to stay ahead of market changes.

Competitors:

Key competitors of Canopy Growth Corp include Aurora Cannabis Inc (ACB), Tilray Inc (TLRY), and Cronos Group Inc (CRON). Canopy Growth Corp competes with these companies in various segments of the cannabis market, including production, distribution, and research and development. Market share percentages show that Canopy Growth Corp is a leading player in the industry, with a strong presence in both the Canadian and international markets.

Competitive advantages of Canopy Growth Corp include its established brand reputation, diversified product offerings, and global distribution network. However, the company also faces disadvantages such as regulatory uncertainties, supply chain challenges, and increasing competition from new entrants in the industry.

Potential Challenges and Opportunities:

Key challenges for Canopy Growth Corp include regulatory changes, supply chain disruptions, and competitive pressures, which could impact the company's growth and profitability. However, potential opportunities such as expanding into new markets, launching innovative products, and forming strategic partnerships present avenues for Canopy Growth Corp to enhance its market position and drive future growth.

Recent Acquisitions (last 3 years):

In the last three years, Canopy Growth Corp has made several strategic acquisitions to strengthen its market position and expand its product portfolio. Some of the notable acquisitions include:

  • Acreage Holdings Inc in 2019: Acreage Holdings is a US-based cannabis company, and the acquisition of this company allowed Canopy Growth Corp to enter the US market and gain a foothold in the growing cannabis industry.

  • This Works in 2019: This Works is a UK-based skincare company, and the acquisition of this company enabled Canopy Growth Corp to diversify its product offerings and tap into the beauty and wellness market.

  • Supreme Cannabis Company in 2021: The acquisition of Supreme Cannabis Company allowed Canopy Growth Corp to strengthen its presence in the Canadian cannabis market and expand its production capacity.

These acquisitions align with Canopy Growth Corp's overall strategy of expanding its market reach and product offerings to drive growth and profitability.

AI-Based Fundamental Rating:

Based on an AI-based fundamental rating system, Canopy Growth Corp's stock fundamentals are rated 7 out of 10. This rating is supported by the company's strong financial performance, market positioning, and growth prospects in the cannabis industry. Canopy Growth Corp's focus on innovation, product quality, and strategic acquisitions have contributed to its competitive advantage and long-term sustainability.

Sources and Disclaimers:

Sources:

  • Canopy Growth Corp website
  • Financial reports and statements from SEC filings
  • Market research reports and industry analysis

Disclaimers: The information provided in this overview is for informational purposes only and should not be used as investment advice. Investors are encouraged to conduct their own research and due diligence before making any investment decisions based on the information presented here.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Canopy Growth Corp

Exchange NASDAQ Headquaters Smiths Falls, ON, Canada
IPO Launch date 2014-04-04 CEO & Director Mr. David Eric Klein
Sector Healthcare Website https://www.canopygrowth.com
Industry Drug Manufacturers - Specialty & Generic Full time employees 1029
Headquaters Smiths Falls, ON, Canada
CEO & Director Mr. David Eric Klein
Website https://www.canopygrowth.com
Website https://www.canopygrowth.com
Full time employees 1029

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​